Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmaceutics II Exam 1 > Part 1 > Flashcards

Part 1 Flashcards

(82 cards)

Start Studying
1
Q

true or false

preformulation studies are ONLY related to the API itself

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

the dosage form includes….

A

the API and all excipients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

true or false

drug substances are often administered alone

A

FALSE

they are administered as part of a formulation, in combination with one or more nonmedical agents (excipients) that serve varied and specialized pharmaceutical functions

drug substances are SELDOM administered alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

name 9 functions of pharmaceutical ingredients

A

solubilize
suspend
stabilize
thicken
dilute
emulsify
preserve
color
flavor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

in a nutshell, what is the function of pharmaceutical ingredients?

A

to fashion medicinal agents into efficacious and appealing dosage forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

each type of ______ is unique in its ____ and _____ characteristics

A

each type of DOSAGE FORM is unique in its PHYSICAL and PHARMACEUTICAL characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

give an example of when we would want to thicken a dosage form

A

in the case of eye drops, we can thicken them to increase the retention time. this minimizes loss of the medication and it needs to be applied less frequently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

do elixirs need a preservative?

A

NO

elixirs have enough alcohol to not need a preservative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

give an example of when a preservative would be needed

A

with a lot of free water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

do large volume IVs need preservative?

A

NO they are single dose. don’t need preservative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

give an example of when a diluent excipient would be needed

A

for the tablet dosage form

especially needed if the drug is a very low dose, as a tiny drug would be impossible to properly handle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

of the 9 functions of pharamaceutical ingredients (excipients), which function is the most important and the biggest concern

A

STABILIZE

for example, vitamin C is highly susceptible to oxidation and needs to be stabilized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

as mentioned, each type of dosage form is unique in its physical and pharmaceutical characteristics

the excipients used is contingent on what?

A

the duration, onset time, etc

the ultimate goal is to obtain the maximum treatment with minimum side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the main concern in the case of stability?

A

the environment–

-oxidation
-hydrolysis (humidity)
-photolysis (light)

also microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

true or false

stability is a concern with both the API itself as well as the entire formulation

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are methods to protect the drug substance from the destructive influences of atmospheric oxygen or humidity?

A

coated tablets and sealed ampuls

oxygen can’t penetrate these things and no microorganisms can come into sealed ampuls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

for which dosage form is gastric acid destruction the biggest concern? what is done to combat it?

A

oral dosage form. gastric acid is an extremely low pH and the API will degrade in this environment. it needs to be protected

enteric coated tablets are produced. these will not dissolve in the stomach (will dissolve at high pH) and cause irritation. the tablet will dissolve in the small intestine instead.

ex: aspirin is weakly acidic and would normally dissolve in the stomach, but enteric coating prevents this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is done to conceal the bitter or bad taste or odor of a drug substance?

A

the use of capsules, coated tablets, and flavored syrups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

explain how capsules are utilized to mask the bad taste of a drug.

wouldn’t capsules still dissolve on the tongue and leave a bad taste?

A

capsules are formulated such that they will not dissolve in the mouth – the shell will not dissolve in cold fluids but only the warmth of our body fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

as long as _________the bitter taste of a drug will not be noticed

A

the drug doesnt release on the tongue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

liquid preparations of drugs substances can be prepared as ___ or ___

A

dispersions (suspensions)
clear preparations (solutions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

true or false

the solid dosage form is normally preferred, but the liquid dosage form is required for some populations

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

which uses a cosolvent system – solutions or suspensions?

A

solutions. cosolvent system is used to ensure that the drug will dissolve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

how can rate-controlled drug action be provided?

A

through various controlled release tablets, capsules, and suspension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
true or false the higher the drug concentration, the higher the solubility
FALSE -- the higher the dissolution rate
26
are suspensions an example of a rate-controlled drug?
yes the solid powder is in the stomach and is slowly dissolving. this controls the dissolution rate -- slowly. will have low concentration available overall, degradation is less and bioavailability is INCREASED as compared to solution. extended duration of therapy. in the case of solutions, it will be subject to quick degradation because all of the drug is already in solution and available for degradation
27
true or false it is easier to optimize drug action of topical drugs as compared to oral drugs
true
28
explain how the insertion of a drug into body orifices is available
through the rectal and vaginal dosage forms
29
what dosage form(s) allow doe the placement of drugs directly into the bloodstream or body tissues?
injections
30
name topical dosage forms (6) topical dosage forms allow for...
ointment cream transdermal patches ophthalmic ear nasal topical dosage forms allow for OPTIMAL DRUG ACTION
31
One of the needs for dosage forms is to provide for optimal drug action through......
both topical administration sites and inhalation therapy (inhalants and inhalation aerosols)
32
how do you increase the retention time at the site of the stomach for a solution dosage form whose site of action is the stomach?
through a viscosity agent to thicken -- will increase the time at the site of action of the stomach will go from stomach to small intestine very quickly if too thin.
33
solutions include......
1. API 2. Solvent(s)
34
true or false most APIs are solid powders
true
35
for a tablet to have an effect what has to happen?
it needs to dissolve
36
what determines if a drug will dissolve?
solute-solute solute-solvent solvent-solvent interactions. through various forces and bonds--- -van der waals -ion-dipole -ion-induced dipole -hydrogen -ion-ion
37
WHAT 3 THINGS NEED TO BE CONSIDERED IN PREFORMULATION STUDIES?
1. physiochemical properties of the drug itself (API -- no excipients yet) 2. Biopharmaceutical considerations (ADME) 3, Therapeutic consderations of the disease state
38
as mentioned, one of the 3 main things to be considered in preformulation are the physiochemical properties of the drug itself. explain this further
-the forces and bonds -the states of matter -stable solid dilutions -UNSTABLE solid dilutions -liquid-aqueous concentrates (mixing elixir w solution) -acids and bases -liquid-oil concentrates of liquids (ie: emulsion) -drug and product stability
39
give an example of a stable, solid dilution AND an unstable, solid dilution
in most cases, 1mg of API combined with 99mg of excipients will be stable unstable -- nitroglycerin. nitroglycerin easily evaporates, so it is not opened in the pharmacy and the patient will receive the full bottle
40
give an example of a liquid-aqueous concentrate. is it any concern?
mixing elixir with solution. this could be an issue because a solution has little to no alcohol content. this can pose a solubility issue
41
explain how biopharmaceutical considerations are something to think about for preformulation
ADME D -- after the drug dissolves, how will it get from plasma to the receptor site? if it doesnt get there, there is no therapeutic effect M -- 1st pass effects of liver. Most of the drug is destroyed in the liver and only a small amount survives to get into circulation
42
true or false when all is said and done, all dosage forms will end up as a solution
true -- they have to dissolve in order to have therapeutic effect
43
true or false the drug only has to reach the receptor site in order to exert therapeutic effect
FALSE -- needs to actually bind to the receptor
44
true or false if the body considers a drug to be "safe", it does not undergo metabolism and 1st pass effects
true
45
what is step 1 of drug design after the drug has been discovered
preformulation studies
46
what is the #1 concern of a solid dosage form
solubility. drug MUST dissolve in order to exert effect
47
under preformulation studies, what "physical description" must be studied?
the appearance, color, odor, and taste
48
why is microscopic examination part of preformulation studies?
the particle size and range of the raw drug substance must be determined, as well as the crystal structure this is related to SOLUBILITY which is the #1 concern of the solid dosage form
49
why is heat of vaporization part of preformulation studies
mainly in determining the vapor pressure for implantable pumps and aerosol dosage forms
50
why is melting point depression part of preformulation studies
if i add "x" excipient, how much will the melting point decrease? for instance, salt lowers the melting point of water to melt snow
51
the higher the molecular weight, the ____ the melting point
higher
52
why is the "phase rule" part of preformulation studies
if we have 2 phases in a formulation, we want to know the interaction between them if we add a surfactant to this, there are now 3 phases -- we want to know the interaction between the 3 phases
53
true or false if the particle size is decreased, there is a substantial increase in solubility
FALSE the intrinsic solubility does not change, but the dissolution rate increases due to higher surface area which makes it faster to prepare HOWEVER, it is also possible for the particle size to be so small that it can't interact with the solvent and dissolve
54
what is the freezing point of water
the freezing point of PURE water is 32 degrees F HOWEVER, impurities can affect the melting/freezing point
55
upon the addition of a second component, which melting point is MORE LOWERED--- -a compound with a low melting point -a compound with a high melting point
the low-melting point compound will be affected to a greater extent (greater lowering of melting point)
56
are pka/dissociation constants part of preformulation studies?
yes expresses the extent of ionization
57
how are organic salts obtained?
from acid base reactions
58
name 5 things that particle size has an effect on (IMPORTANT)
-drug dissociation rate -bioavailability -content uniformity -flow characteristics -sedimentation rates
59
one of the parameters that particle size has an effect on is bioavailability. explain what this is
the amount of drug available in systemic circulation and is thus able to have an effect
60
explain how particle size affects content uniformity
if small and large particles are mixed together (not uniform), the large particles will sink and the dose will not be right
61
explain how particle size affects flow characteristics
capsule/tablet dosage form is preferred. when manufacturing in the industry, the powder to make the tablet/capsule needs to flow evenly so that all the dosage forms are even and uniform
62
what are the methods of evaluating particle size?
1. Sieving or screening 2. Microscopy 3. Sedimentation 4. Stream scanning (coulter counter, hiac counter)
63
when the particle size of water insoluble drugs is reduced, ____ increases, this results in higher _____
DISSOLUTION RATE increases and this results in higher AVAILABILITY AT THE ABSOPRTION SITE (bioavailability)
64
what is sieving
like sifting in baking. method to evaluate particle size
65
what is microscopy
method of evaluating particle size AND crystal structure
66
what is stream scanning
includes coulter counter and hiac counter. method to evaluate particle size and the number of particles. a shadow is created to find out this information
67
true or false the particle size of the API is the only concern
FALSE -- both API and excipients. want a similar size between them
68
particle size is most especially important in ____ dosage form
parenteral
69
if reducing the particle size doesn't work to dissolve, what can be done next?
polymorphism
70
true or false if a drug is water soluble, bioavailability isn't really a concern
TRUE water soluble molecules don't undergo first pass effects and are able to dissolve in the blood
71
____-____% of drugs in the market use polymorphic API does this need a new NDA?
15-20% YES when going from crystalline to amorphous form, the drug is considered new and an NDA is needed
72
many new drugs are water insoluble. this can be combatted by reducing the amount of API in the formulation. does this need a NDA? what is the concern with this?
does NOT need an NDA this is a concern bc reducing the amount of API can affect the bioavailability. we need a sufficient bioavailability to have therapeutic effect
73
which has a higher dissolution rate -- amorphous or crystal form?
amourphous
74
when a drug precipitates, energy is ______ and it is now _____
when a drug precipitates, energy is RELEASED and it is now STABLE LOW SOLUBILITY requires energy to reintroduce to liquid state
75
is more energy required to go from liquid to solid or solid to liquid?
solid to liquid
76
when a polymorphic drug is compared to a crystalline drug, which requires more energy from outside to transform the compound from solid to liquid?
crystalline requires MORE ENERGY to change
77
do polymorphic drugs contain energy?
yes, they retain some energy
78
which has a lower melting point -- polymorphic or crystalline form?
polymorphic
79
true or false different polymorphs of the same drugs have the same physiochemical properties
FALSE this is why the FDA considers it a new drug and requires a new NDA
80
different polymorphs can have different ____,_____, and ____
density vapor pressure and stability
81
how are polymorphs prepared?
the drug is rapidly precipitated from the solvent which does not allow the drug molecules enough time to form an orderly array. the drug is rapidly cooled and spray dryed/freeze dried the goal is to retain ENERGY in the structure BUT we also want it to have a decent stability and dissolution
82

Pharmaceutics II Exam 1 (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions